Bedel Financial Consulting’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-2,368
| Closed | -$292K | – | 293 |
|
|
2025
Q3 | $292K | Buy |
2,368
+2
| +0.1% | +$248 | 0.04% | 219 |
|
|
2025
Q2 | $284K | Buy |
2,366
+1
| +0% | +$133 | 0.04% | 223 |
|
|
2025
Q1 | $319K | Buy |
2,365
+2
| +0.1% | +$305 | 0.05% | 202 |
|
|
2024
Q4 | $345K | Hold |
2,363
| – | – | 0.05% | 198 |
|
|
2024
Q3 | $385K | Buy |
2,363
+2
| +0.1% | +$296 | 0.05% | 167 |
|
|
2024
Q2 | $322K | Buy |
2,361
+2
| +0.1% | +$278 | 0.05% | 186 |
|
|
2024
Q1 | $361K | Buy |
2,359
+1
| +0% | +$149 | 0.06% | 168 |
|
|
2023
Q4 | $336K | Buy |
2,358
+1
| +0% | +$133 | 0.06% | 171 |
|
|
2023
Q3 | $309K | Buy |
2,357
+2
| +0.1% | +$304 | 0.06% | 170 |
|
|
2023
Q2 | $375K | Buy |
2,355
+1,055
| +81% | +$170K | 0.08% | 150 |
|
|
2023
Q1 | $206K | Sell |
1,300
-1,054
| -45% | -$158K | 0.05% | 217 |
|
|
2022
Q4 | $330K | Hold |
2,354
| – | – | 0.08% | 153 |
|
|
2022
Q3 | $339K | Hold |
2,354
| – | – | 0.09% | 145 |
|
|
2022
Q2 | $332K | Buy |
2,354
+164
| +7% | +$23.4K | 0.1% | 139 |
|
|
2022
Q1 | $304K | Sell |
2,190
-569
| -21% | -$87.2K | 0.1% | 141 |
|
|
2021
Q4 | $481K | Buy |
2,759
+9
| +0.3% | +$1.5K | 0.15% | 102 |
|
|
2021
Q3 | $455K | Hold |
2,750
| – | – | 0.16% | 97 |
|
|
2021
Q2 | $495K | Hold |
2,750
| – | – | 0.17% | 90 |
|
|
2021
Q1 | $530K | Hold |
2,750
| – | – | 0.21% | 77 |
|
|
2020
Q4 | $555K | Buy |
2,750
+280
| +11% | +$57.9K | 0.25% | 60 |
|
|
2020
Q3 | $519K | Hold |
2,470
| – | – | 0.26% | 58 |
|
|
2020
Q2 | $542K | Sell |
2,470
-7
| -0.3% | -$1.4K | 0.29% | 53 |
|
|
2020
Q1 | $429K | Buy |
2,477
+7
| +0.3% | +$1.16K | 0.28% | 57 |
|
|
2019
Q4 | $379K | Hold |
2,470
| – | – | 0.21% | 82 |
|
|
2019
Q3 | $375K | Hold |
2,470
| – | – | 0.23% | 85 |
|
|
2019
Q2 | $378K | Hold |
2,470
| – | – | 0.23% | 86 |
|
|
2019
Q1 | $396K | Hold |
2,470
| – | – | 0.25% | 74 |
|
|
2018
Q4 | $381K | Hold |
2,470
| – | – | 0.27% | 71 |
|
|
2018
Q3 | $367K | Hold |
2,470
| – | – | 0.24% | 82 |
|
|
2018
Q2 | $334K | Hold |
2,470
| – | – | 0.25% | 86 |
|
|
2018
Q1 | $329K | Hold |
2,470
| – | – | 0.25% | 82 |
|
|
2017
Q4 | $367K | Buy |
+2,470
| New | +$336K | 0.33% | 69 |
|
Other funds holding CLX
Bedel Financial Consulting's CLX Position: Q4 2025 in Review
Bedel Financial Consulting sold out of Clorox (CLX) in Q4 2025, closing a stake of 2,368 shares — an estimated $292K sold.
Bedel Financial Consulting first reported a position in CLX in Q4 2017 and held it in 32 quarters. The position peaked at $555K in Q4 2020. 1,050 funds tracked by Wall St. Rank hold CLX as of Q4 2025.
- Bedel Financial Consulting reported no remaining Clorox position as of Q4 2025 after selling out during the quarter.
- Bedel Financial Consulting sold 2,368 Clorox shares in Q4 2025, an estimated $292K.
- Bedel Financial Consulting first reported a position in Clorox in Q4 2017 and held it in 32 quarters.
- Bedel Financial Consulting's Clorox position peaked at $555K in Q4 2020.
- 1,050 funds tracked by Wall St. Rank held Clorox as of Q4 2025.
Based on Bedel Financial Consulting's 13F filing for Q4 2025, filed 28 Jan 2026.